Title |
Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature
|
---|---|
Published in |
Immunologic Research, August 2016
|
DOI | 10.1007/s12026-016-8820-z |
Pubmed ID | |
Authors |
Beniamino Palmieri, Dimitri Poddighe, Maria Vadalà, Carmen Laurino, Carla Carnovale, Emilio Clementi |
Abstract |
Human papilloma virus (HPV) is recognized as a major cause for cervical cancer among women worldwide. Two HPV vaccines are currently available: Gardasil(®) and Cervarix(®). Both vaccines enclose viral antigenic proteins, but differ as to the biological systems of culture and the adjuvant components. Recently, a collection of symptoms, indicating nervous system dysfunction, has been described after HPV vaccination. We retrospectively described a case series including 18 girls (aged 12-24 years) referred to our "Second Opinion Medical Network" for the evaluation of "neuropathy with autonomic dysfunction" after HPV vaccination. All girls complained of long-lasting and invalidating somatoform symptoms (including asthenia, headache, cognitive dysfunctions, myalgia, sinus tachycardia and skin rashes) that have developed 1-5 days (n = 11), 5-15 days (n = 5) and 15-20 days (n = 2) after the vaccination. These cases can be included in the recently described immune dysfunction named autoimmune/inflammatory syndrome induced by adjuvants (ASIA). HPV vaccine, through its adjuvant component, is speculated to induce an abnormal activation of the immune system, involving glia cells in the nervous system too. Further researches should aim at defining the pathological and clinical aspects of these post-vaccination diseases and identifying a genetic background predisposing to these adverse reactions. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 64 | 14% |
Brazil | 24 | 5% |
Japan | 21 | 5% |
Canada | 10 | 2% |
United Kingdom | 7 | 2% |
Italy | 3 | <1% |
France | 3 | <1% |
Ireland | 3 | <1% |
Netherlands | 3 | <1% |
Other | 30 | 7% |
Unknown | 285 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 422 | 93% |
Practitioners (doctors, other healthcare professionals) | 18 | 4% |
Scientists | 9 | 2% |
Science communicators (journalists, bloggers, editors) | 3 | <1% |
Unknown | 1 | <1% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 120 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 14 | 12% |
Student > Bachelor | 14 | 12% |
Student > Master | 13 | 11% |
Researcher | 11 | 9% |
Student > Doctoral Student | 10 | 8% |
Other | 26 | 21% |
Unknown | 33 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 31% |
Nursing and Health Professions | 9 | 7% |
Biochemistry, Genetics and Molecular Biology | 9 | 7% |
Agricultural and Biological Sciences | 3 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
Other | 12 | 10% |
Unknown | 47 | 39% |